These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 10706740

  • 1. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS, Yamada K, Womer KL, Pillsbury EP, Allison KS, Marolewski AE, Geng D, Thall AD, Arn JS, Sachs DH, Sayegh MH, Madsen JC.
    J Immunol; 2000 Mar 15; 164(6):3434-44. PubMed ID: 10706740
    [Abstract] [Full Text] [Related]

  • 2. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
    Arpinati M, Terragna C, Chirumbolo G, Rizzi S, Urbini B, Re F, Tura S, Baccarani M, Rondelli D.
    Exp Hematol; 2003 Jan 15; 31(1):31-8. PubMed ID: 12543104
    [Abstract] [Full Text] [Related]

  • 3. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL.
    Eur J Immunol; 1999 Aug 15; 29(8):2367-75. PubMed ID: 10458748
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
    Popma SH, Krasinskas AM, Kreisel D, Szeto W, McLean AD, Moore JS, Rosengard BR.
    Transplant Proc; 2001 Aug 15; 33(1-2):767-9. PubMed ID: 11267061
    [No Abstract] [Full Text] [Related]

  • 5. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN, Wille U, Craig L, Linsley PS, Rennick DM, Peach R, Hunter CA.
    Infect Immun; 2000 May 15; 68(5):2837-44. PubMed ID: 10768980
    [Abstract] [Full Text] [Related]

  • 6. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
    Van Gool SW, Zhang Y, Kasran A, de Boer M, Ceuppens JL.
    Scand J Immunol; 1996 Jul 15; 44(1):21-9. PubMed ID: 8693288
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J, Bingaman AW, Durham MM, Pearson TC, Larsen CP.
    Transpl Immunol; 2001 Oct 15; 9(1):13-7. PubMed ID: 11680567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
    Shanafelt MC, Kang I, Barthold SW, Bockenstedt LK.
    Infect Immun; 1998 Jan 15; 66(1):266-71. PubMed ID: 9423867
    [Abstract] [Full Text] [Related]

  • 16. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
    Ito D, Ogasawara K, Iwabuchi K, Inuyama Y, Onoé K.
    J Immunol; 2000 Feb 01; 164(3):1230-5. PubMed ID: 10640735
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J, Sakurai J, Saito K, Tani K, Asano S, Azuma M.
    Clin Exp Immunol; 2002 Jul 01; 129(1):61-8. PubMed ID: 12100023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.